Literature DB >> 10424732

Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours.

J C Nicholson1, F M Ross, J A Kohler, D W Ellison.   

Abstract

The objective of this study was to test the hypothesis that chromosomal imbalances in central nervous system primitive neuroectodermal tumours (PNETs) reflect site and histology. We used comparative genomic hybridization to study 37 cases of PNET, of which four were cerebral and 31 were medulloblastomas classified histologically as classic (n = 17) or nodular/desmoplastic (n = 14). Tumour immunophenotype was characterized with antibodies to neuroglial, mesenchymal and epithelial markers. Chromosomal imbalances were detected in 28 medulloblastomas (90%), and significant associations between tumour variants and genetic abnormalities were demonstrated. Aberrations suggesting isochromosome 17q were present in eight (26%) medulloblastomas, of which seven were classic variants. None of these cases, or a further six with gain of 17q, showed immunoreactivity for glial fibrillary acidic protein. Loss on 9q was found in six cases (19%), five of them nodular/desmoplastic. Loss of 22 occurred in four (13%), all classic medulloblastomas in young patients with a poor outcome and immunoreactivity for more than one epithelial or mesenchymal marker. Different patterns of imbalance were found in the cerebral PNETs. There were no abnormalities of chromosome 17, but all three cases with imbalance showed losses of 3p12.3-p14.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424732      PMCID: PMC2363061          DOI: 10.1038/sj.bjc.6690525

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  43 in total

1.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

2.  Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4.

Authors:  D Pinkel; J Landegent; C Collins; J Fuscoe; R Segraves; J Lucas; J Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Monosomy 22 in rhabdoid or atypical tumors of the brain.

Authors:  J A Biegel; L B Rorke; R J Packer; B S Emanuel
Journal:  J Neurosurg       Date:  1990-11       Impact factor: 5.115

Review 4.  Medulloblastoma: II. A pathobiologic overview.

Authors:  F H Tomlinson; B W Scheithauer; R B Jenkins
Journal:  J Child Neurol       Date:  1992-07       Impact factor: 1.987

5.  Evolutionary conservation of the EPS8 gene and its mapping to human chromosome 12q23-q24.

Authors:  W T Wong; F Carlomagno; T Druck; C Barletta; C M Croce; K Huebner; M H Kraus; P P Di Fiore
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

6.  "Desmoplastic" versus "classic" medulloblastoma: comparison of DNA content, histopathology and differentiation.

Authors:  F Giangaspero; P Chieco; C Ceccarelli; G Lisignoli; R Pozzuoli; M Gambacorta; G Rossi; P C Burger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Prognostic factors in medulloblastoma, including DNA ploidy.

Authors:  C Zerbini; R D Gelber; D Weinberg; S E Sallan; P Barnes; W Kupsky; R M Scott; N J Tarbell
Journal:  J Clin Oncol       Date:  1993-04       Impact factor: 44.544

8.  Deletion mapping of the medulloblastoma locus on chromosome 17p.

Authors:  P H Cogen; L Daneshvar; A K Metzger; M S Edwards
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

9.  Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases.

Authors:  T Maraziotis; E Perentes; E Karamitopoulou; Y Nakagawa; E C Gessaga; A Probst; A Frankfurter
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system.

Authors:  J A Biegel; L B Rorke; R J Packer; L N Sutton; L Schut; K Bonner; B S Emanuel
Journal:  Genes Chromosomes Cancer       Date:  1989-11       Impact factor: 5.006

View more
  9 in total

Review 1.  Pediatric brain tumors: current treatment strategies and future therapeutic approaches.

Authors:  Sabine Mueller; Susan Chang
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

2.  Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation.

Authors:  J Nicholson; C Wickramasinghe; F Ross; J Crolla; D Ellison
Journal:  Mol Pathol       Date:  2000-12

Review 3.  Recent advances in embryonal tumours of the central nervous system.

Authors:  Chitra Sarkar; Prabal Deb; Mehar Chand Sharma
Journal:  Childs Nerv Syst       Date:  2005-01-29       Impact factor: 1.475

4.  Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.

Authors:  Suzanne Miller; Hazel A Rogers; Paul Lyon; Vikki Rand; Martyna Adamowicz-Brice; Steven C Clifford; James T Hayden; Sara Dyer; Stefan Pfister; Andrey Korshunov; Marie-Anne Brundler; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

Review 5.  Medulloblastoma: recurrence and metastasis.

Authors:  Donya Aref; Sidney Croul
Journal:  CNS Oncol       Date:  2013-07

6.  Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.

Authors:  Martin G McCabe; L Magnus Bäcklund; Hui Sun Leong; Koichi Ichimura; V Peter Collins
Journal:  Neuro Oncol       Date:  2011-02-02       Impact factor: 12.300

7.  Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.

Authors:  M Carter; J Nicholson; F Ross; J Crolla; R Allibone; V Balaji; R Perry; D Walker; R Gilbertson; D W Ellison
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

Review 8.  MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.

Authors:  Maria Braoudaki; George I Lambrou
Journal:  J Hematol Oncol       Date:  2015-02-06       Impact factor: 17.388

9.  Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.

Authors:  Balsam Rizeq; Saïd Sif; Gheyath K Nasrallah; Allal Ouhtit
Journal:  J Cell Mol Med       Date:  2020-09-05       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.